Skip to main content


European Journal of Nuclear Medicine and Molecular Imaging

European Journal of Nuclear Medicine and Molecular Imaging OnlineFirst articles

23.02.2018 | Letter to the Editor

Reply to: “All that glitters is not gold – new reconstruction methods using Deauville criteria for patient reporting”

23.02.2018 | Original Article

18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer

The standard treatment for advanced epithelial ovarian cancer (EOC) consists of surgery and chemotherapy [ 1 ]. The primary purpose of surgery is to reduce the amount of macroscopic tumor to, preferably, no macroscopic residuals (R0 resection) …

23.02.2018 | Original Article

Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is the fourth-most common cause of cancer death [ 1 ]. Currently, radical resection of the primary tumor and regional lymphadenectomy are the only potentially curative treatments. Despite recent improvements …

23.02.2018 | Original Article

Optimal time-point for 68Ga-PSMA-11 PET/CT imaging in assessment of prostate cancer: feasibility of sterile cold-kit tracer preparation?

Prostate cancer (PCa) is the most prevalent cancer and the third most common cause of cancer-associated death in men [ 1 , 2 ]. About 15% of PCa patients have high-risk disease and have a higher incidence of extraglandular disease at the time of …

22.02.2018 | Original Article Open Access

Automated SPECT analysis compared with expert visual scoring for the detection of FFR-defined coronary artery disease

Myocardial perfusion imaging (MPI) using single-photon emission computed tomography (SPECT) is widely used for non-invasive diagnosis of obstructive coronary artery disease (CAD) [ 1 ]. In general, SPECT studies are graded based on visual …

Aktuelle Ausgaben

Über diese Zeitschrift

Highly ranked among journals in its field, the European Journal of Nuclear Medicine and Molecular Imaging provides a forum for the exchange of clinical and scientific information for the nuclear medicine community and allied professions involved in the functional, metabolic and molecular investigation of disease. The journal remains of primary interest to practitioners in the field of nuclear medicine but also reports on original work relating to physics, dosimetry, radiation biology, radiochemistry and pharmacy. Original material examines the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.
The Journal publishes in-depth reviews of topical interest, short communications, controversies, interesting images and letters to the Editor.

This is the official journal of the European Association of Nuclear Medicine (EANM). EANM members, and also members of the Japanese, Korean and Italian nuclear medicine societies have free access to EJNMMI. As part of this reciprocal agreement, EANM members also have free access to “Annals of Nuclear Medicine”, “Nuclear Medicine and Molecular Imaging” and to “Clinical and Translational Imaging”.

Weitere Informationen